EFHD2 and non-small cell lung carcinoma: In NSCLC, EF-hand domain-containing protein D2 (EFHD2) could upregulate NOX4-induced ROS production of A549 and H1299 cells, which ultimately increases transporter ATP-binding cassette subfamily C member 1 expression to elevate cisplatin efflux.